![Henry E. Blair](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Henry E. Blair
Plus aucun poste en cours
Profil
Henry E.
Blair was the founder of GelTex Pharmaceuticals, Inc. (1991), Dyax Corp.
(1989), and Genzyme Corp.
(1981) where he held the titles of Chairman, and Director respectively.
Mr. Blair is also the founder of Biocode, Inc. Mr. Blair's former jobs include Director positions at Celtrix Pharmaceuticals, Inc., DynaGen, Inc., and rEVO Biologics, Inc. He also served as an Advisor at BioVentures Investors and as a Trustee at Immune Disease Institute, Inc.
Anciens postes connus de Henry E. Blair
| Sociétés | Poste | Fin |
|---|---|---|
| DYAX CORP. | Directeur Général | 01/04/2007 |
BioVentures Investors
 BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors. | Private Equity Investor | 31/03/2009 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Fondateur | 24/05/2007 |
Biocode, Inc.
 Biocode, Inc. Office Equipment/SuppliesProducer Manufacturing Develops techniques to provide brand protection and identification to prevent counterfeiting | Fondateur | - |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Celtrix Pharmaceuticals, Inc.
 Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops potential therapeutic products | Health Technology |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
DynaGen, Inc.
 DynaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops and wholesales proprietary & generic therapeutic and diagnostic products for the human health care market | Health Technology |
Biocode, Inc.
Biocode, Inc. Office Equipment/SuppliesProducer Manufacturing Develops techniques to provide brand protection and identification to prevent counterfeiting | Producer Manufacturing |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors. | Finance |
Immune Disease Institute, Inc.
 Immune Disease Institute, Inc. Immune Disease Institute, Inc. provides biomedical research services. It engages in doing fundamental research to improve human health, harness inflammation, and strengthen immune defense. The company was founded on January 19, 1953 and is headquartered in Boston, MA. | |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
Choisissez Zonebourse 
